Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

bone marrow involvement, and B-symptoms. Prognostic Value of [18 F]Fluorodeoxyglucose Positron Emission Tomography in the Posttreatment Response Evaluation of Follicular Lymphoma Ninety-nine ...

Leukemias and lymphomas are often grouped together because they are both blood-related cancers that originate in lymphocytes. However, leukemia originates in the bone marrow and spreads through the ...

Lymphoma is a type of cancer that begins in ... tumor of lymphoid cells and can develop in the lymph nodes, spleen, bone marrow, blood or other organs.

Caimi explained that the findings showed that “1 year of the triplet combination seems to be better than the doublet in patients with relapsed follicular lymphoma.” ...

Bone involvement was associated with a significantly elevated risk for brain metastases among female individuals with follicular thyroid cancer. Women with follicular thyroid cancer (FTC) with bone ...

Borrowing nature's blueprint: How scientists replicated bone marrow Date: January 30, 2025 Source: University of Pennsylvania School of Engineering and Applied Science Summary: Researchers have ...

Myelofibrosis is a type of blood cancer that causes scarring (fibrosis) in your bone marrow, which affects how your body makes blood cells. When your bone marrow has trouble making blood cells ...